Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties

Virk-Baker, Mandeep K.; Martin, Michelle Y.; Levine, Robert S.; Wang, Xin; Nagy, Tim R.; Pisu, Maria

doi:10.1007/s10552-013-0295-9

Cited by 17 publications

(11 citation statements)

References 39 publications

(57 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NHB women have been reported to be approximately 20% less likely to receive adequate mammographic screening than NHW women (7). However, several reports indicated that mammographic screening has been comparable between these groups in more recent years (8,9).…”

Section: Introductionmentioning

confidence: 99%

Impact of Patient–Provider Race, Ethnicity, and Gender Concordance on Cancer Screening: Findings from Medical Expenditure Panel Survey

Malhotra

Rotter

Tsui

et al. 2017

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

Racial and ethnic minorities experience lower rates of cancer screening compared with non-Hispanic whites (NHWs). Previous studies evaluating the role of patient-provider race, ethnicity, or gender concordance in cancer screening have been inconclusive. In a cross-sectional analysis using the Medical Expenditure Panel Survey (MEPS), data from 2003 to 2010 were assessed for associations between patient-provider race, ethnicity, and/or gender concordance and, screening (American Cancer Society guidelines) for breast, cervical, and colorectal cancer. Multivariable logistic analyses were conducted to examine associations of interest. Of the 32,041 patient-provider pairs in our analysis, more than 60% of the patients were NHW, 15% were non-Hispanic black (NHB), and 15% were Hispanic. Overall, patients adherent to cancer screening were more likely to be non-Hispanic, better educated, married, wealthier, and privately insured. Patient-provider gender discordance was associated with lower rates of breast [OR, 0.83; 95% confidence interval (CI), 0.76-0.90], cervical (OR, 0.83; 95% CI, 0.76-0.91), and colorectal cancer (OR, 0.84; 95% CI, 0.79-0.90) screening in all patients. This association was also significant after adjusting for racial and/or ethnic concordance. Conversely, among NHWs and NHBs, patient-provider racial and/or ethnic concordance was not associated with screening. Among Hispanics, patient-provider ethnic discordant pairs had higher breast (58% vs. 52%) and colorectal cancer (45% vs. 39%) screening rates compared with concordant pairs. Patient-provider gender concordance positively affected cancer screening. Patient-provider ethnic concordance was inversely associated with receipt of cancer screening among Hispanics. This counter-intuitive finding requires further study. Our findings highlight the importance of gender concordance in improving cancer screening rates. .

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of Patient–Provider Race, Ethnicity, and Gender Concordance on Cancer Screening: Findings from Medical Expenditure Panel Survey

Malhotra

Rotter

Tsui

et al. 2017

Cancer Epidemiology, Biomarkers &Amp; Prevention

View full text Add to dashboard Cite

show abstract

“…Influenza vaccination has previously been used to determine use of routine preventive services, because it is recommended for all adults. 16,17 Statistical significance was set at 0.05, and all tests were 2-tailed. Data analysis and statistical testing was performed using R version 3.5 (R Foundation for Statistical Computing).…”

Section: Discussionmentioning

confidence: 99%

“…Because influenza vaccination is recommended universally for adults, all patients should be interacting with the healthcare system on at least an annual basis, and hence this surrogate has been used previously. 16,17 Third, we investigated the number of patients receiving care from a mental health professional, which more accurately identifies patients with more severe psychiatric burden. 25 The explanation for the high rates of early mental disorders among patients with gastrointestinal cancer in the current study is likely multifactorial.…”

Section: Discussionmentioning

confidence: 99%

Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies

Harris

Kashyap

Humphreys

et al. 2021

Journal of the National Comprehensive Cancer Network

View full text Add to dashboard Cite

Background: Patients with cancer are at high risk for having mental disorders, resulting in widespread psychosocial screening efforts. However, there is a need for population-based and longitudinal studies of mental disorders among patients who have gastrointestinal cancer and particular among elderly patients. Patients and Methods: We used the SEER-Medicare database to identify patients aged ≥65 years with colorectal, pancreatic, gastric, hepatic/biliary, esophageal, or anal cancer. Earlier (12 months before or up to 6 months after cancer diagnosis) and subsequent mental disorder diagnoses were identified. Results: Of 112,283 patients, prevalence of an earlier mental disorder was 21%, 23%, 20%, 20%, 19%, and 26% for colorectal, pancreatic, gastric, hepatic/biliary, esophageal, and anal cancer, respectively. An increased odds of an earlier mental disorder was associated with pancreatic cancer (odds ratio [OR], 1.17; 95% CI, 1.11–1.23), esophageal cancer (OR, 1.10; 95% CI, 1.02–1.18), and anal cancer (OR, 1.17; 95% CI, 1.05–1.30) compared with colorectal cancer and with having regional versus local disease (OR, 1.09; 95% CI, 1.06–1.13). The cumulative incidence of a subsequent mental disorder at 5 years was 19%, 16%, 14%, 13%, 12%, and 10% for patients with anal, colorectal, esophageal, gastric, hepatic/biliary, and pancreatic cancer, respectively. There was an association with having regional disease (hazard ratio [HR], 1.08; 95% CI, 1.04–1.12) or distant disease (HR, 1.36; 95% CI, 1.28–1.45) compared with local disease and the development of a mental disorder. Although the development of a subsequent mental disorder was more common among patients with advanced cancers, there continued to be a significant number of patients with earlier-stage disease at risk. Conclusions: This study suggests a larger role for incorporating psychiatric symptom screening and management throughout oncologic care.

show abstract

“…The observed increase in incidence among non-Hispanic black and Asian or Pacific Islander women is likely due to the already increasing incidence within stage. The increased screening utilization among blacks 37–39 may contribute to the increased incidence. However, some studies suggest that the observed higher utilization of mammograms in blacks may partly because of self-reported mammogram use tends to overestimate mammogram rates in blacks than in whites.…”

Section: Discussionmentioning

confidence: 99%

Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines

Guo

Kuo

Berenson

2019

American Journal of Preventive Medicine

View full text Add to dashboard Cite

Introduction: The U.S. Preventive Services Task Force changed breast cancer screening guidelines in November 2009 for mammograms in women aged 40–49 and 50–74 years. The aim of this study was to assess the impact of the 2009 guideline changes on breast cancer incidence by stage among women aged 40–49 and 50–74 years in the U.S. Methods: This was a cross-sectional trend analysis of the impact of 2009 guideline change on breast cancer incidence by stage, using data from the National Program for Cancer Registries and Surveillance, Epidemiology, and End Results Incidence–U.S. Cancer Statistics 2001–2014 database among women aged 40–74 years. Incidence was age adjusted to the U.S. standard population. Data were collected in 2001–2014, released in 2017, and analyzed in 2018. Results: Among women aged 40–49 years, the 4-year average annual incidence of breast cancer increased slightly in 2011–2014 for in situ, localized, and distant cancer, but decreased for regional cancer compared with the incidence in 2006–2009. Among women aged 50–74 years, the 4-year average annual incidence of breast cancer increased in 2011–2014 for localized and distant cancer, but decreased for in situ and regional cancer. Joinpoint analyses revealed that annual percentage changes decreased after 2009 for distant cancer among both women aged 40– 49 and 50–74 years. The composition of breast cancer by stage was similar between 2006–2009 and 2011–2014 among both women aged 40–49 and 50–74 years. Conclusions: Changes in breast cancer screening by the 2009 U.S. Preventive Services Task Force guidelines had little immediate adverse effects on the stage distribution of breast cancer diagnoses in the U.S. Monitoring the incidence by cancer stages over time is needed.

show abstract

Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties

Cited by 17 publications

References 39 publications

Impact of Patient–Provider Race, Ethnicity, and Gender Concordance on Cancer Screening: Findings from Medical Expenditure Panel Survey

Impact of Patient–Provider Race, Ethnicity, and Gender Concordance on Cancer Screening: Findings from Medical Expenditure Panel Survey

Longitudinal Analysis of Mental Disorder Burden Among Elderly Patients With Gastrointestinal Malignancies

Breast Cancer Incidence by Stage Before and After Change in Screening Guidelines

Contact Info

Product

Resources

About